Cited by 2Sperm and Testicular FunctionReproductive Health and TechnologiesMale Reproductive Health Studies

Recommendations for Human Sperm Morphology Assessment in 2025: An Expert Review From the French BLEFCO Group

Open access
Gatimel, Nicolas, Barbotin, Anne‐Laure, Mery, Lionel, Beauvillard, Damien, Bendayan, Marion, Boursier, Angèle, Boueilh, Thomas, Pereira, Bruno +7 more·2026·Andrology

Abstract

Background: Numerous publications have questioned the lack of analytical reliability and clinical relevance of sperm morphology assessment for infertility workup and before use of assisted reproductive techniques (ART). There is a huge variability in the performance and interpretation of this test. It has become necessary to evaluate its true medical service rendered to the patient. Objectives: To develop clinical guidelines for use of spermatozoa morphology assessment during male fertility check‐up and before ART. Materials and Methods: These guidelines were produced following a pre‐defined standard methodology for narrative and Patient Intervention Comparison Outcomes (PICO) questions. The French Working Group (WG) on Sperm Morphology Assessment consisted of 15 members including an expert in statistics. Results: R1: WG does not recommend systematic detailed analysis of abnormalities (or groups of abnormalities) during sperm morphology assessment. R2: WG recommends that the laboratory should use a qualitative or quantitative method for detection of a monomorphic abnormality (globozoospermia, macrocephalic spermatozoa syndrome, pinhead spermatozoa syndrome, multiple flagellar abnormalities). The result may be given as an interpretative commentary or as a numerical report of the percentage of detailed abnormalities. R3: There is insufficient evidence to demonstrate the clinical value of indexes of multiple sperm defects (TZI, SDI, MAI) in investigation of infertility and before ART. Accordingly, the working group does not recommend the use of sperm abnormality indexes (TZI, SDI, MAI) in sperm morphology assessment. R4: WG gives a positive opinion on the use of automated systems based on cytological analysis after staining after qualification of the operators, and validation of the analytical performance within their own laboratory. R5: WG does not recommend using the percentage of spermatozoa with normal morphology as a prognostic criterion before IUI, IVF, or ICSI, or as a tool for selecting the ART procedure. Discussion: This article examines the clinical interest of sperm morphology assessment during fertility check‐up and before ART. The overall level of evidence from studies is low, challenging current practices regarding sperm morphology assessment. Conclusion: These guidelines suggest a significant simplification of sperm morphology assessment in the light of the examined publications while maintaining the detection of monomorphic sperm abnormalities.

AI snapshot

Written from the paper’s full text.

TL;DR

This French BLEFCO expert review recommends simplifying human sperm morphology assessment, abandoning routine detailed abnormality analysis and multiple-defect indexes, while retaining detection of monomorphic abnormalities. It concludes that the percentage of normal sperm forms should not be used prognostically before IUI, IVF, or ICSI or to select the ART procedure.

Key findings

  • The working group issued five recommendations: R1 do not systematically perform detailed analysis of abnormalities; R2 use a qualitative or quantitative method to detect monomorphic abnormalities (globozoospermia, macrocephalic spermatozoa syndrome, pinhead/acephalic spermatozoa syndrome, MMAF); R3 do not use TZI, SDI, or MAI; R4 automated systems based on cytological analysis after staining are acceptable after operator qualification and local analytical validation; R5 do not use the percentage of normal morphology as a prognostic criterion before IUI, IVF, or ICSI or as a tool for selecting ART.
  • Evidence was generally low: PICO 1 analysed 27 publications, PICO 2 analysed 23 (22/23 low Grade 1 or 2), PICO 3 analysed 18 (17/18 low Grade 1 or 2), and PICO 4 analysed 12 (10/12 low Grade 1 or 2).
  • For ICSI, 13 of 16 studies found no impact of teratozoospermia on fertilisation rates and 12 of 14 found no impact on pregnancy rates; for conventional IVF, most studies analysed (79%, with low evidence) showed teratozoospermia did not decrease pregnancy chances.
  • In a prospective cohort of fertile controls undergoing contraceptive vasectomy, 55.9% had teratozoospermia <4%, and 86.8% carried head abnormalities.

Methods

  • A BLEFCO working group of 15 experts, including reproductive biologists from private (n = 5) and public academic sectors (n = 9) and a statistical analyst, developed seven key questions: three narrative questions and four PICO questions.
  • PubMed/Medline was searched for PICO questions from January 2000 to July 2025; each publication was independently assessed by two GDG members for effect/clinical relevance and bias, with GRADE scores assigned and consensus defined as acceptance >70%.
  • Because available evidence was limited and heterogeneous, with mostly retrospective studies and no randomised trials, the group used a structured narrative review and expert consensus rather than a formal systematic review and meta-analysis.

Limitations

  • Stated: the overall level of evidence from studies is low, most studies were retrospective, no randomised trials were available, and studies were exclusively Grades 1 and 2; the group therefore could not make strong recommendations or support current practices.
  • Stated: PICO analyses were affected by non-comparable populations, failure to account for female factors, differing teratozoospermia cut-offs, and lack of adjustment for other sperm parameters.
  • Evident from the text: the recommendations rely on expert consensus and narrative review rather than a formal systematic review or meta-analysis, and the working group itself notes that studies designed to demonstrate the clinical usefulness of sperm morphology assessment are lacking.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1111/andr.70134

Cites

110 of 110 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

68 of 119 cited sources checked · 37 supported · 0 flagged · accuracy not yet measured

  • Premisecitation

    No genetic mutation has been identified in patients with <50% globozoospermia.

    “No genetic mutation has been identified in patients with < 50% globozoospermia [29].”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [29] T. Celse, C. Cazin, F. Mietton, et al., “ Genetic Analyses of a Large Cohort of Infertile Patients With Globozoospermia, DPY19L2 Still the Main Actor, GGN Confirmed as a Guest Player,” Human Genetics 140, no. 1 (2021): 43– 57, https://doi.org10.1007/s00439‐020‐02229‐0 33108537 source

      The Diagnostic performances section reports no positive DPY19L2 diagnosis among the study’s patients with less than 50% globozoospermia. The claim omits those limits: the finding concerns DPY19L2 screening in this cohort, not an absence of any genetic mutation in all such patients. (LLM, conf=0.87)

      Experimental — accuracy not yet measured
  • Premisecitation

    In this cohort, 86.8% of fertile men carry head abnormalities.

    “In this cohort, we can also see the low predictivity of head abnormalities because 86.8% of these fertile men carry them [10, 22].”
    Quote in the paperSubstantial claim2 of 2 sources checked
    • cites [10] L. Cheng, D. Miller, A. Wecht, D. Pelzman, and K. Hwang, “ The Questionable Clinical Utility of Sperm Morphology: Rate of Isolated Teratospermia in a Population of Fertile Men,” Journal of Sexual Medicine 21 (2024): qdae002.189, 10.1093/jsxmed/qdae002.189 PMC11228780 38983740 source

      The Results (page unavailable) identify head-shape defects as the most common abnormality in this fertile cohort, but report 59 men (84.3%), not 86.8%. The claimed 86.8% can be calculated from 59 divided by the 68 men reported to have complete morphology assessments, so the source's counts support that figure even though its printed percentage differs. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
    • cites [22] Corrigendum to ‘High Rate of Isolated Teratospermia in a Population of Fertile Men and the Questionable Clinical Utility of Sperm Morphology’ [F&S Reports 5 (2024) 140‐144]. F S Rep 2025; 6(1): 101. https://doi.org10.1016/j.xfre.2024.11.005 40201105 PMC11973682 source

      The corrigendum’s Abstract and corrected Table 2 report normal morphology for 30 of 68 men (44.1%), but give no rate of head abnormalities. A search for “86.8%” and head abnormalities found no supporting passage in our copy; the corrigendum says the morphologic-abnormality-type section was removed from Table 2. (LLM, conf=0.75)

      Experimental — accuracy not yet measured
  • Premisecitation

    Detailed abnormalities are of low clinical diagnostic value with the exception of monomorphic syndromes.

    “In a previous literature review, focusing on the clinical relevance of detailed morphology assessment with a view to andrological diagnosis during fertility workup, we have demonstrated detailed abnormalities are of low clinical diagnostic value with the exception of the monomorphic syndromes.”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [4] N. Gatimel, J. Moreau, J. Parinaud, and R. D. Leandri, “ Sperm Morphology: Assessment, Pathophysiology, Clinical Relevance, and State of the Art in 2017,” Andrology 5, no. 5 (2017): 845– 862, https://doi.org10.1111/andr.12389 28692759 source
  • Premisecitation

    The method for sperm morphology assessment, the stains used, the thresholds that define teratozoospermia, and the morphological classifications employed suffer from extreme heterogeneity over time and between laboratories.

    “The method for sperm morphology assessment, the stains used, the thresholds that define teratozoospermia, as well as the morphological classifications employed, suffer from extreme heterogeneity over time and between laboratories [4].”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [4] N. Gatimel, J. Moreau, J. Parinaud, and R. D. Leandri, “ Sperm Morphology: Assessment, Pathophysiology, Clinical Relevance, and State of the Art in 2017,” Andrology 5, no. 5 (2017): 845– 862, https://doi.org10.1111/andr.12389 28692759 source
  • Premisecitation

    In a prospective cohort of fertile controls undergoing contraceptive vasectomy, 55.9% had teratozoospermia <4%.

    “A recent article again points to the poor clinical relevance of sperm morphology assessment, showing that in their prospective cohort of fertile controls undergoing contraceptive vasectomy, 55.9% had teratozoospermia < 4%.”
    Quote in the paperSubstantial claim2 of 2 sources checked
    • cites [10] L. Cheng, D. Miller, A. Wecht, D. Pelzman, and K. Hwang, “ The Questionable Clinical Utility of Sperm Morphology: Rate of Isolated Teratospermia in a Population of Fertile Men,” Journal of Sexual Medicine 21 (2024): qdae002.189, 10.1093/jsxmed/qdae002.189 PMC11228780 38983740 source
    • cites [22] Corrigendum to ‘High Rate of Isolated Teratospermia in a Population of Fertile Men and the Questionable Clinical Utility of Sperm Morphology’ [F&S Reports 5 (2024) 140‐144]. F S Rep 2025; 6(1): 101. https://doi.org10.1016/j.xfre.2024.11.005 40201105 PMC11973682 source

      The corrected Table 2 (Abstract; no page given) reports that 30 of 68 men (44.1%) had normal morphology >4%, leaving 38 (55.9%) at or below 4%. It does not establish that all 38 were strictly below 4%, and this corrigendum does not describe the cohort as prospective or say its participants were undergoing contraceptive vasectomy. (LLM, conf=0.82)

      Experimental — accuracy not yet measured
  • May combine two claims. 47
  • Classified as probably not a substantial claim. 12
  • May combine two claims.

    Premisecitation

    The origin and impact of certain traits or morphological abnormalities are still not clear, probably because the occurrence of these abnormalities is physiological in human spermatozoa cells.

    “Looking at publications over more than the last 30 years, the origin and the impact of certain traits or morphological abnormalities are still not clear, probably because the occurrence of these abnormalities is physiological in human spermatozoa cells [4].”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [4] N. Gatimel, J. Moreau, J. Parinaud, and R. D. Leandri, “ Sperm Morphology: Assessment, Pathophysiology, Clinical Relevance, and State of the Art in 2017,” Andrology 5, no. 5 (2017): 845– 862, https://doi.org10.1111/andr.12389 28692759 source
  • Classified as probably not a substantial claim.

    Premisecitation

    There is a high prevalence of severe teratozoospermia in fertile men.

    “Recently, some authors have shown the high prevalence of severe teratozoospermia in fertile men [9, 10] and pointed out the low clinical value of this test [11].”
    Quote in the paperSubstantial claim2 of 2 sources checked
    • cites [9] J. R. Kovac, R. P. Smith, M. Cajipe, D. J. Lamb, and L. I. Lipshultz, “ Men With a Complete Absence of Normal Sperm Morphology Exhibit High Rates of Success Without Assisted Reproduction,” Asian Journal of Andrology 19, no. 1 (2017): 39– 42, https://doi.org10.4103/1008‐682X.189211 27751992 PMC5227671 source

      The Results report that some men with severe teratozoospermia (0% normal forms) conceived naturally. But the study selected men undergoing an infertility work-up and measured conception among those with severe teratozoospermia; it did not measure how prevalent severe teratozoospermia is among fertile men. (LLM, conf=0.85)

      Experimental — accuracy not yet measured
    • cites [10] L. Cheng, D. Miller, A. Wecht, D. Pelzman, and K. Hwang, “ The Questionable Clinical Utility of Sperm Morphology: Rate of Isolated Teratospermia in a Population of Fertile Men,” Journal of Sexual Medicine 21 (2024): qdae002.189, 10.1093/jsxmed/qdae002.189 PMC11228780 38983740 source

      The Results report that 38 of 68 fertile men (55.9%) had 3% or fewer normal-shaped sperm, supporting a high prevalence of abnormal morphology. However, the paper does not classify that group as having severe teratozoospermia; it reports only two men with 0% normal morphology. The supplied copy gives no page number. (LLM, conf=0.85)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation

    Macrozoospermia may be of iatrogenic origin, as described after treatment with sulphasalazine for ulcerating colitis and Crohn's disease, and in this context the abnormality is reversible and may resolve when the treatment is changed.

    “Alternately, macrozoospermia may be of iatrogenic origin, as described after treatment with sulphasalazine for ulcerating colitis and Crohn's disease. In this context, the abnormality is reversible and may resolve when the treatment is changed [52, 53].”
    Quote in the paperNot a substantial claim1 of 2 sources checked
    • cites [52] A. Toth, “ Reversible Toxic Effect of Salicylazosulfapyridine on Semen Quality,” Fertility and Sterility 31, no. 5 (1979): 538– 540. 36307 source

      The Abstract (page not specified) reports a characteristic megalo cell type during salicylazosulfapyridine treatment for chronic ulcerative colitis and dramatic improvement in overall semen quality after three patients stopped the drug. It does not study Crohn’s disease or establish that the megalo-cell abnormality itself resolved, rather than semen quality overall. (LLM, conf=0.85)

      Experimental — accuracy not yet measured
    • cites [53] M. J. Cosentino, W. Y. Chey, H. Takihara, and A. T. Cockett, “ The Effects of Sulfasalazine on Human Male Fertility Potential and Seminal Prostaglandins,” Journal of Urology 132, no. 4 (1984): 682– 686. 6147421 source
  • Classified as probably not a substantial claim.

    Premisecitation

    Van den Hoven et al. concluded that sperm morphology is not a useful tool to predict ongoing pregnancy rate after conventional IVF.

    “The authors concluded that sperm morphology is not a useful tool to predict ongoing pregnancy rate after conventional IVF.”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [98] L. van den Hoven, J. C. Hendriks, J. G. Verbeet, J. R. Westphal, and A. M. Wetzels, “ Status of Sperm Morphology Assessment: An Evaluation of Methodology and Clinical Value,” Fertility and Sterility 103, no. 1 (2015): 53– 58, https://doi.org10.1016/j.fertnstert.2014.09.036 25450299 source
  • May combine two claims.

    Premisecitation

    Macrozoospermia is associated with an increased risk of sperm aneuploidy, and of polyploidy in particular.

    “Numerous studies have shown an association between macrozoospermia and an increased risk of sperm aneuploidy, and of polyploidy in particular [38, 39, 40, 41] (Supporting Information S1).”
    Quote in the paperSubstantial claim1 of 4 sources checked
    • cites [38] S. Viville, R. Mollard, M. L. Bach, C. Falquet, P. Gerlinger, and S. Warter, “ Do Morphological Anomalies Reflect Chromosomal Aneuploidies?: Case Report,” Human Reproduction 15, no. 12 (2000): 2563– 2566. 11098027 source
    • cites [39] B. Guthauser, F. Vialard, M. Dakouane, V. Izard, M. Albert, and J. Selva, “ Chromosomal Analysis of Spermatozoa With Normal‐Sized Heads in Two Infertile Patients With Macrocephalic Sperm Head Syndrome,” Fertility and Sterility 85, no. 3 (2006): e5– e7, https://doi.org10.1016/j.fertnstert.2005.07.1334 16500351 source
    • cites [40] A. Perrin, F. Morel, L. Moy, D. Colleu, V. Amice, and M. De Braekeleer, “ Study of Aneuploidy in Large‐Headed, Multiple‐Tailed Spermatozoa: Case Report and Review of the Literature,” Fertility and Sterility 90, no. 4 (2008): e13– e17, https://doi.org10.1016/j.fertnstert.2007.09.013 18166187 source
    • cites [41] C. Coutton, J. Escoffier, G. Martinez, C. Arnoult, and P. F. Ray, “ Teratozoospermia: Spotlight on the Main Genetic Actors in the Human,” Human Reproduction Update 21, no. 4 (2015): 455– 485, https://doi.org10.1093/humupd/dmv020 25888788 source
  • May combine two claims.

    Premisecitation

    A single study observed higher pregnancy rates after ICSI, but only in the subgroup of patients with severe teratozoospermia (<2%).

    “A single study observed higher pregnancy rates after ICSI, but only in the subgroup of patients with severe teratozoospermia (< 2%) [99].”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [99] Y. Zhu, F. Zhang, H. Cheng, X. X. Sun, and F. Jiang, “ Modified Strict Sperm Morphology Threshold Aids in the Clinical Selection of Conventional In Vitro Fertilization (IVF) or Intracytoplasmic Sperm Injection (ICSI),” Asian Journal of Andrology 24, no. 1 (2022): 62– 66, https://doi.org10.4103/aja.aja_45_21 34135171 PMC8788610 source
  • May combine two claims.

    Premisecitation

    Li et al. showed in 3922 IVF and 843 ICSI attempts that the fertilisation rate decreased with the percentage of morphologically normal sperm in conventional IVF but not in ICSI.

    “In this retrospective study of 3922 IVF and 843 ICSI attempts, the authors showed that the fertilisation rate decreased with the percentage of morphologically normal sperm in conventional IVF but not in ICSI.”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [101] B. Li, Y. Ma, J. Huang, et al., “ Probing the Effect of Human Normal Sperm Morphology Rate on Cycle Outcomes and Assisted Reproductive Methods Selection,” PLoS ONE 9, no. 11 (2014): e113392, https://doi.org10.1371/journal.pone.0113392 25411962 PMC4239063 source
  • May combine two claims.

    Premisecitation

    Two other studies reported no effect of technique on fertilisation rates, while two studies paradoxically reported higher fertilisation rates with IVF than with ICSI in cases of severe teratozoospermia (normal forms <1%).

    “Two others studies reported no effect of technique on fertilisation rates [101, 106] while two studies paradoxically reported higher fertilisation rates with IVF than with ICSI in cases of severe teratozoospermia (normal forms < 1%).”
    Quote in the paperNot a substantial claim2 of 2 sources checked
    • cites [101] B. Li, Y. Ma, J. Huang, et al., “ Probing the Effect of Human Normal Sperm Morphology Rate on Cycle Outcomes and Assisted Reproductive Methods Selection,” PLoS ONE 9, no. 11 (2014): e113392, https://doi.org10.1371/journal.pone.0113392 25411962 PMC4239063 source
    • cites [106] M. Stimpfel, N. Jancar, E. Vrtacnik‐Bokal, I. Virant‐Klun, “ Conventional IVF Improves Blastocyst Rate and Quality Compared to ICSI When Used in Patients With Mild or Moderate Teratozoospermia,” Systems Biology in Reproductive Medicine 65, no. 6 (2019): 458– 464, https://doi.org10.1080/19396368.2019.1666436 31522570 source
  • May combine two claims.

    Premisecitation

    A Grade 3 study in couples undergoing a first IVF/ICSI cycle retrospectively compared the impact of a change in selection criteria for ICSI between two time periods; after adjustment for confounding factors, no significant difference was reported in fertilisation rate, pregnancy rate or live birth rate between these two periods.

    “Lastly, a Grade 3 study in couples undergoing a first IVF/ICSI cycle retrospectively compared the impact of a change in selection criteria for ICSI between two time periods [109]. After adjustment for confounding factors (female age, male age, ovarian reserve, sperm concentration and progressive motility, number of oocytes inseminated, number of embryos transferred, embryo stage at transfer), no”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [109] B. Woolnough, D. Shmorgun, M. C. Leveille, E. Sabri, and J. Gale, “ Does Omitting Teratospermia as a Selection Criterion for ICSI Change Pregnancy Rates?,” Journal of Assisted Reproduction and Genetics 37, no. 8 (2020): 1895– 1901, https://doi.org10.1007/s10815‐020‐01827‐1 32449098 PMC7468002 source

      Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation

    The importance of distinguishing between monomorphic and polymorphic forms is decisive in patient management and has recently been noted by other authors.

    “The importance of distinguishing between monomorphic and polymorphic forms is decisive in‐patient management and has recently been noted by other authors [111].”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [111] C. Wyns, P. Vogiatzi, R. Saleh, R. Shah, and A. Agarwal, “ Sperm Morphology Value in Assisted Reproduction: Dismantling an Enigma and Key Takeaways for the Busy Clinician,” Therapeutic Advances in Reproductive Health 18 (2024): 26334941241303888, https://doi.org10.1177/26334941241303888 39651461 PMC11624537 source
  • May combine two claims.

    Study design and conductreasoning

    The first study [103] contained numerous factors of bias and the study design did not allow a conclusion as to the predictive value of sperm morphology analysis before ICSI.

    “The first one [103] contained numerous factors of bias and the study design did not allow a conclusion as to the predictive value of sperm morphology analysis before ICSI.”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [103] A. Moubasher, T. Abdel‐Raheem, H. Ahmed, A. Salem, A. Doshi, and A. Abdel Raheem, “ An Open Prospective Study on Whether Intracytoplasmic Morphologically Selected Sperm Injection (IMSI) Offers a Better Outcome Than Conventional Intracytoplasmic Sperm Injection (ICSI),” Cureus 13, no. 11 (2021): e19181, https://doi.org10.7759/cureus.19181 34737916 PMC8560014 source

      The Conclusions (page unavailable) acknowledge limitations of the open prospective design and unequal ICSI and IMSI group sizes. However, the paper does not say that numerous biases prevented a conclusion about the predictive value of sperm morphology analysis before ICSI; it studied outcomes of two injection procedures and drew a conclusion about their relative benefit. (LLM, conf=0.79)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation

    Concerning fertilisation rate, one of the two randomised oocyte cohort studies found no significant impact on fertilisation rates, whereas the other observed higher fertilisation rates with ICSI than with IVF (72.6% vs 44.1%, p < 0.05).

    “Concerning fertilisation rate, one of this two found no significant impact on fertilisation rates [104], whereas the other observed higher fertilisation rates with ICSI than with IVF (72.6% vs. 44.1%, p < 0.05) [105].”
    Quote in the paperNot a substantial claim2 of 2 sources checked
    • cites [104] W. Fan, S. W. Li, L. Li, et al., “ Outcome of Conventional IVF and ICSI on Sibling Oocytes in the Case of Isolated Teratozoospermia,” Journal of Assisted Reproduction and Genetics 29, no. 9 (2012): 905– 910, https://doi.org10.1007/s10815‐012‐9823‐x 22733316 PMC3463669 source
    • cites [105] P. E. Kihaile, J. Misumi, K. Hirotsuru, Y. Kumasako, R. E. Kisanga, and T. Utsunomiya, “ Comparison of Sibling Oocyte Outcomes After Intracytoplasmic Sperm Injection and In Vitro Fertilization in Severe Teratozoospermic Patients in the First Cycle,” International Journal of Andrology 26, no. 1 (2003): 57– 62. 12534939 source
  • May combine two claims.

    Study design and conductcitation

    This study [99], graded level of evidence 1, presented several factors of bias, in particular the possible association of teratozoospermia with other sperm abnormalities, and also the limited number of IVF cycles analysed in this subgroup (n=46).

    “However, this study, graded level of evidence 1, presented several factors of bias, in particular the possible association of teratozoospermia with other sperm abnormalities, and also the limited number of IVF cycles analysed in this subgroup (n = 46).”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [99] Y. Zhu, F. Zhang, H. Cheng, X. X. Sun, and F. Jiang, “ Modified Strict Sperm Morphology Threshold Aids in the Clinical Selection of Conventional In Vitro Fertilization (IVF) or Intracytoplasmic Sperm Injection (ICSI),” Asian Journal of Andrology 24, no. 1 (2022): 62– 66, https://doi.org10.4103/aja.aja_45_21 34135171 PMC8788610 source

      Split into 2 atoms — 1 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 1 unverifiable. Expand the claim to see per-atom verdicts.

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation

    A study compared results between patients with isolated teratozoospermia (<4% strict criteria) (n=183) and a group with entirely normal sperm parameters (n=258) in attempts with at least eight oocytes, with half the oocytes randomised to IVF and half to ICSI; no significant difference was found in fertilisation rates, embryo morphology at Day 3, pregnancy rates or miscarriage rates between the IVF

    “A study compared results between patients with isolated teratozoospermia (< 4% strict criteria) (n = 183) and a group of patients with entirely normal sperm parameters (n = 258) in attempts with at least eight oocytes, with half the oocytes randomised to IVF and half to ICSI. No significant difference was found in fertilisation rates, embryo morphology at Day 3, pregnancy rates or miscarriage”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [104] W. Fan, S. W. Li, L. Li, et al., “ Outcome of Conventional IVF and ICSI on Sibling Oocytes in the Case of Isolated Teratozoospermia,” Journal of Assisted Reproduction and Genetics 29, no. 9 (2012): 905– 910, https://doi.org10.1007/s10815‐012‐9823‐x 22733316 PMC3463669 source

      Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

      Experimental — accuracy not yet measured
  • May combine two claims.

    Findingcitation

    Only two studies found an impact of teratozoospermia on pregnancy rates after ICSI, and they were Grade 1.

    “Only two studies found an impact of teratozoospermia on pregnancy rates after ICSI, and they were Grade 1 [102, 103].”
    Quote in the paperSubstantial claim2 of 2 sources checked
    • cites [102] G. Cito, R. Picone, R. Fucci, et al., “ Sperm Morphology: What Implications on the Assisted Reproductive Outcomes?,” Andrology 8, no. 6 (2020): 1867– 1874, https://doi.org10.1111/andr.12883 32761795 source

      The Discussion reports higher clinical pregnancy rates when normal sperm morphology exceeded 6% in ICSI cycles using donor oocytes, supporting this paper as a study finding an association. Our copy does not establish that only two studies found such an impact or assign this study a Grade 1 rating. (LLM, conf=0.83)

      Experimental — accuracy not yet measured
    • cites [103] A. Moubasher, T. Abdel‐Raheem, H. Ahmed, A. Salem, A. Doshi, and A. Abdel Raheem, “ An Open Prospective Study on Whether Intracytoplasmic Morphologically Selected Sperm Injection (IMSI) Offers a Better Outcome Than Conventional Intracytoplasmic Sperm Injection (ICSI),” Cureus 13, no. 11 (2021): e19181, https://doi.org10.7759/cureus.19181 34737916 PMC8560014 source

      The Introduction and Discussion associate sperm-head abnormalities with lower pregnancy rates, but neither section reports an analysis of teratozoospermia and pregnancy rates after ICSI. A search for teratozoospermia and Grade 1 studies found no passage establishing that only two studies found such an impact or that this study was one of them. (LLM, conf=0.73)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Findingnone given

    Monomorphic abnormalities are often associated with genetic defects.

    “Monomorphic abnormalities are often associated with genetic defects.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S4 (based).

    Findingnone given

    All studies cited in the sixth edition of the WHO recommendations were conducted over 20 years ago.

    “However, the current relevance of these assertions may be questioned, as all the studies cited in the sixth edition of the WHO recommendations were conducted over 20 years ago.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingreasoning

    The available evidence and studies on sperm morphology assessment are of limited quality and heterogeneity, mostly retrospective, with no randomised trials, and exclusively Grades 1 and 2.

    “Given the limited quality and heterogeneity of the available evidence and studies (retrospective study for most of them, absence of randomised trial, studies of Grades 1 and 2 exclusively), a formal systematic review and meta‐analysis did not seem appropriate for robust results.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S4 (based). May combine two claims.

    Findingnone given

    The overall level of evidence from studies is low, challenging current practices regarding sperm morphology assessment.

    “The overall level of evidence from studies is low, challenging current practices regarding sperm morphology assessment.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingnone given

    Analytical performances are mediocre for analysis of the percentage of normal forms as well as for detailed assessment of the abnormalities.

    “Performances are mediocre for analysis of the percentage of normal forms as well as for detailed assessment of the abnormalities.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingcitation

    Studies designed to independently evaluate the predictive value of sperm morphology in IUI are scarce and show discordant results.

    “Studies designed to independently evaluate the predictive value of sperm morphology in IUI, either by multivariate analyses [74, 75, 77, 79, 80, 84, 90, 91, 93, 95, 96] or by study of patients with isolated teratozoospermia [78, 91, 92] are scarce and show discordant results.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim.

    Findingnone given

    Following the advent of IUI, data on the subject are numerous and contradictory.

    “Following the advent of IUI, data on the subject are numerous and contradictory.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim.

    Findingnone given

    There is no consensual cut-off in the literature to define monomorphic or pre-dominant abnormalities.

    “There is no consensual cut‐off in the literature to define monomorphic or pre‐dominant abnormalities.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S4 (based).

    Findingnone given

    The great majority of studies of globozoospermia or acephalic spermatozoa syndromes have been carried out in populations with monomorphic abnormalities (with 100% or nearly 100% of heads affected).

    “The great majority of studies of globozoospermia or acephalic spermatozoa syndromes have been carried out in populations with monomorphic abnormalities (with 100% or nearly 100% of heads affected).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    In the comprehensive analysis of publications from 2000 onwards for PICO3, 13 of 16 found no impact of teratozoospermia on fertilisation rates after ICSI and 12 of 14 found no impact on pregnancy rates.

    “In our comprehensive analysis of publications from 2000 onwards, 13 of 16 found no impact of teratozoospermia on fertilisation rates after ICSI and 12 of 14 found no impact on pregnancy rates.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingnone given

    Only two studies have compared the performances of IVF and ICSI after randomisation of the oocyte cohorts for each attempt, with conflicting conclusions.

    “Only two studies have compared the performances of IVF and ICSI after randomisation of the oocyte cohorts for each attempt with conflicting conclusions.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    Globozoospermic men are infertile and some are able to achieve a pregnancy after ICSI.

    “Globozoospermic men were infertile and some were able to achieve a pregnancy after ICSI.”
    Quote in the paperNot a substantial claim0 of 4 sources checked
    • cites [30] J. Liu, Z. Nagy, H. Joris, H. Tournaye, P. Devroey, and A. Van Steirteghem, “ Successful Fertilization and Establishment of Pregnancies After Intracytoplasmic Sperm Injection in Patients With Globozoospermia,” Human Reproduction 10, no. 3 (1995): 626– 629. 7782443 source
    • cites [31] D. E. Battaglia, J. K. Koehler, N. A. Klein, and M. J. Tucker, “ Failure of Oocyte Activation After Intracytoplasmic Sperm Injection Using Round‐Headed Sperm,” Fertility and Sterility 68, no. 1 (1997): 118– 122. 9207595 source
    • cites [32] A. V. Rybouchkin, F. Van der Straeten, J. Quatacker, P. De Sutter, and M. Dhont, “ Fertilization and Pregnancy After Assisted Oocyte Activation and Intracytoplasmic Sperm Injection in a Case of Round‐Headed Sperm Associated With Deficient Oocyte Activation Capacity,” Fertility and Sterility 68, no. 6 (1997): 1144– 1147. 9418715 source
    • cites [33] L. Chansel‐Debordeaux, S. Dandieu, S. Bechoua, and C. Jimenez, “ Reproductive Outcome in Globozoospermic Men: Update and Prospects,” Andrology 3, no. 6 (2015): 1022– 1034, https://doi.org10.1111/andr.12081 26445006 source
  • May combine two claims.

    Study design and conductown data

    Seventeen of eighteen studies analysed for PICO3 were classified as having a low level of evidence (Grade 1 or 2) with very good inter-rater agreement (88.9%, kappa 0.81).

    “Seventeen of eighteen studies analysed were classified as having a low level of evidence (Grade 1 or 2) with very good inter‐rater agreement (88.9%, kappa 0.81) (Table 2).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationreasoning

    Results relating to ongoing pregnancy rates and delivery rates varied according to the duration of the couple's infertility, female factors (age, ovarian reserve) and cause of infertility, all factors often not taken into account in the studies analysed.

    “The results relating to ongoing pregnancy rates and delivery rates varied according to the duration of the couple's infertility, female factors (age, ovarian reserve) and cause of infertility, all factors that were often not taken into account in the studies analysed.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Study design and conductown data

    For PICO2, Grade 1 was assigned to 14 of 23 studies, Grade 2 to 8 of 23, and Grade 3 to 1 of 23.

    “Grade 1 (14 of 23), Grade 2 (8 of 23), Grade 3 (1 of 23).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    44.8% of questioned clinicians rarely or never take sperm abnormality indexes into account for the diagnosis of infertility, and 50% rarely or never consider them for the choice or prognosis of an ART technique.

    “Recent data show there is a lack of support from clinicians for this type of index, because 44.8% of those questioned rarely or never take them into account for the diagnosis of infertility, and 50% rarely or never consider them for the choice or prognosis of an ART technique [12].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [12] N. Gatimel, L. Mansoux, J. Moreau, J. Parinaud, and R. D. Leandri, “ The Continued Existence of Significant Disparities in the Technical Practices of Sperm Morphology Assessment and the Clinical Implications: Results of a French Questionnaire,” Fertility and Sterility 107 (2016): 365– 372, https://doi.org10.1016/j.fertnstert.2016.10.038 27887717 source
  • May combine two claims.

    Interpretationreasoning

    In cases of monomorphic syndrome with nearly 100% macrocephalic spermatozoa or when an AURKC mutation is identified, ICSI is ineffective and contra-indicated.

    “In conclusion, in cases of monomorphic syndrome with nearly 100% macrocephalic spermatozoa or when an AURKC mutation is identified, ICSI is ineffective and contra‐indicated.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Premisecitation

    Deveneau et al. found that the number of motile spermatozoa after preparation was the most important parameter affecting pregnancy rate after insemination and considered that sperm morphology should not influence recommendations for offering IUI.

    “The authors found that the number of motile spermatozoa after preparation was the most important parameter affecting pregnancy rate after insemination and considered that sperm morphology should not influence the recommendations for offering a couple intrauterine insemination.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [77] N. E. Deveneau, O. Sinno, M. Krause, et al., “ Impact of Sperm Morphology on the Likelihood of Pregnancy After Intrauterine Insemination,” Fertility and Sterility 102, no. 6 (2014): 1584– 1590, https://doi.org10.1016/j.fertnstert.2014.09.016 25439801 source
  • May combine two claims.

    Study design and conductown data

    In the comprehensive analysis of publications after 2000 for PICO2, 22 of 23 studies used the WHO strict criteria current at the time of publication, and only one used David's modified classification.

    “In our comprehensive analysis of publications after 2000, 22 of 23 studies used the WHO strict criteria that were current at the time of publication, and only one used David's modified classification.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    The MAI and TZI were correlated with fertility in vivo, but their sensitivity and specificity were mediocre (<75%).

    “The MAI [3, 70] and the TZI were correlated with fertility in vivo, but their sensitivity and specificity were mediocre (< 75%).”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites [3] R. Slama, F. Eustache, B. Ducot, et al., “ Time to Pregnancy and Semen Parameters: A Cross‐Sectional Study Among Fertile Couples From Four European Cities,” Human Reproduction 17, no. 2 (2002): 503– 515, https://doi.org10.1093/humrep/17.2.503 11821304 source
    • cites [70] P. Jouannet, B. Ducot, D. Feneux, and A. Spira, “ Male Factors and the Likelihood of Pregnancy in Infertile Couples. I. Study of Sperm Characteristics [Research Support, Non‐U.S. Gov't],” International Journal of Andrology 11, no. 5 (1988): 379– 394. 3235207 source
  • May combine two claims.

    Premisenone given

    If fertilisation takes place in globozoospermia, embryo development does not appear to be affected and the miscarriage rate does not increase.

    “If fertilisation does take place, embryo development does not appear to be affected and the miscarriage rate does not increase.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Study design and conductnone given

    Many studies compared pregnancy outcomes according to levels of teratozoospermia without describing the other sperm parameters, whereas teratozoospermia is often associated with oligoasthenozoospermia.

    “Many studies compared pregnancy outcomes according to levels of teratozoospermia without describing the other sperm parameters, whereas teratozoospermia is often associated with oligoasthenozoospermia.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: Teratozoospermia is often associated with oligoasthenozoospermia.
  • May combine two claims.

    Study design and conductreasoning

    The majority of studies finding an impact of sperm morphology on IUI were published over 10 years ago and contained factors of bias (retrospective, male populations not comparable, female parameters not always taken into account).

    “However, the majority of these studies were published over 10 years ago and they contained the same factors of bias as earlier studies (retrospective study, male populations not comparable for sperm parameters other than morphology, female parameters not always taken into account).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationreasoning

    Literature data show that sperm abnormality indexes can be useful in epidemiological studies or for research purposes, but they do not appear to be a pertinent and validated diagnostic tool in the management of an infertile couple.

    “Literature data show that these indexes can be useful in epidemiological studies or for research purposes, but they do not appear to be a pertinent and validated diagnostic tool in the management of an infertile couple.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Study design and conductown data

    Among bias factors in PICO2, most studies did not concern isolated teratozoospermia and did not detail the male and female characteristics of the groups.

    “Among these factors of bias, most studies did not concern isolated teratozoospermia and did not detail the male and female characteristics of the groups.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Study design and conductown data

    Agreement between readers was strong for the analysis of effect (78.3% agreement, kappa 0.56) and study bias (91.3% agreement, kappa 0.82) in PICO2.

    “Agreement between readers was also strong for the analysis of effect (E) (clinical relevance of the study results) (78.3% agreement, kappa 0.56) and study bias (91.3% agreement, kappa 0.82) (Table 2).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationnone given

    IUI outcome is correlated with the number of motile spermatozoa after preparation, and this is not sufficiently considered in studies of the influence of morphology on outcome.

    “IUI outcome is correlated with the number of motile spermatozoa after preparation, and this is not sufficiently considered in studies of the influence of morphology on outcome.”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: The number of motile spermatozoa after preparation is an important determinant of pregnancy rate after IUI.
  • May combine two claims.

    Premisecitation

    The MMAF phenotype is frequently associated with a significant decrease in sperm motility, ICSI is indicated in most cases, and ICSI outcomes for couples with MMAF do not differ irrespective of the genetic defect.

    “As the MMAF phenotype is frequently associated with a significant decrease in sperm motility, ICSI is indicated in most cases and ICSI outcomes for couples with MMAF do not differ, irrespective of the genetic defect [69].”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [69] L. Ferreux, M. Bourdon, A. Chargui, et al., “ Genetic Diagnosis, Sperm Phenotype and ICSI Outcome in Case of Severe Asthenozoospermia With Multiple Morphological Abnormalities of the Flagellum,” Human Reproduction 36, no. 11 (2021): 2848– 2860, https://doi.org10.1093/humrep/deab200 34529793 source
  • May combine two claims.

    Interpretationreasoning

    The contradictory findings on sperm morphology and IUI are probably related to large intra- and interlaboratory differences in evaluation of morphology, differences in teratozoospermia cut-off values between studies, and differences in the population studied.

    “The contradictory findings are probably related to large intra‐ and interlaboratory differences in evaluation of morphology, to differences in teratozoospermia cut‐off values between studies (< 4%, < 5%, < 15%, etc.) and to differences in the population studied.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Study design and conductreasoning

    The studies on sperm morphology and IUI were all retrospective and their populations were not comparable.

    “However, these were all retrospective studies and their populations were not comparable (isolated teratozoospermia or moderate oligoasthenoteratozoospermia [OATS]).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    In the prospective study by Erdem et al., the percentage of normal forms before and after preparation was significantly higher among patients who achieved a birth in the male infertility subgroup only, and not in the group with unexplained infertility.

    “In the prospective study by Erdem et al. [86], the percentage of normal forms (before and after preparation) was significantly higher among patients who achieved a birth in the male infertility subgroup only, and not in the group with unexplained infertility.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [86] M. Erdem, A. Erdem, M. F. Mutlu, et al., “ The Impact of Sperm Morphology on the Outcome of Intrauterine Insemination Cycles With Gonadotropins in Unexplained and Male Subfertility,” European Journal of Obstetrics, Gynecology, and Reproductive Biology 197 (2016): 120– 124, https://doi.org10.1016/j.ejogrb.2015.12.014 26745391 source
  • May combine two claims.

    Study design and conductown data

    In total, 22 of 23 studies analysed for PICO2 were classified as having a low level of evidence (Grade 1 or 2) with very strong inter-rater agreement (95.7% agreement, kappa 0.92).

    “In total, 22 of 23 studies analysed were classified as having a low level of evidence (Grade 1 or 2) with very strong inter‐rater agreement (95.7% agreement, kappa 0.92) (Table 2): Grade 1 (14 of 23), Grade 2 (8 of 23), Grade 3 (1 of 23).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductnone given

    All articles were analysed by two readers with a high level of agreement between readers.

    “All articles were analysed by two readers with a high level of agreement between readers.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationreasoning

    The main arguments to explain the lack of correlation between sperm abnormalities identified by sperm morphology assessment before ART and ICSI outcome are that ICSI procedure makes it possible to bypass certain obstacles to natural fertilisation and that during an ICSI attempt, the spermatozoon injected is not necessarily representative of the population that underwent morphological analysis.

    “The main arguments to explain the lack of correlation between the sperm abnormalities identified by sperm morphology assessment before ART and ICSI outcome are that ICSI procedure make it possible to bypass certain obstacles to natural fertilisation and that during an ICSI attempt, the spermatozoon injected is not necessarily representative of the population that underwent morphological analysis.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim.

    Interpretationreasoning

    The recent literature and the low level of evidence of the studies analysed lead us not to consider the percentage of normal forms (particularly if teratozoospermia is an isolated abnormality) when deciding between IVF or ICSI.

    “The recent literature and the low level of evidence of the studies analysed, lead us not to consider the percentage of normal forms (particularly if teratozoospermia is an isolated abnormality) when deciding between IVF or ICSI.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationreasoning

    Sperm morphology assessment suffers from major analytical weaknesses and its clinical value has never been validated by studies with a high level of evidence that evaluated its benefit in the medical management of the couple.

    “This test suffers from major analytical weaknesses and its clinical value has never been validated by studies with a high level of evidence that evaluated its benefit in the medical management of the couple, for example, in randomised trials.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Study design and conductown data

    Most of the studies analysed for PICO4 (10 of 12) were classified as having a low level of evidence (Grade 1 or 2) with moderate inter-rater agreement (91.7%, kappa 0.84).

    “Most of the studies analysed (10 of 12) were classified as having a low level of evidence (Grade 1 or 2) with moderate inter‐rater agreement (91.7%, kappa 0.84) (Table 2).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisereasoning

    In male infertility, the choice between IVF and ICSI is scarcely influenced by sperm morphology, because there are no applicable recommendations and polymorphic teratozoospermia is very often associated with OATS, which determines the indication of ICSI.

    “In male infertility, the choice between IVF and ICSI is scarcely influenced by sperm morphology, because on the one hand there are no applicable recommendations, and on the other hand polymorphic teratozoospermia is very often associated with OATS, which determines the indication of ICSI.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: Polymorphic teratozoospermia is very often associated with OATS, which determines the indication of ICSI.
  • May combine two claims.

    Study design and conductown data

    Grades for PICO3 were markedly affected by bias in all studies: 13 of 18 presented very numerous factors of bias.

    “Grades were markedly affected by bias in all studies: 13 of 18 presented very numerous factors of bias.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S4 (based).

    Interpretationnone given

    This approach is warranted given the well-documented issues with reproducibility and repeatability in sperm morphology analysis.

    “This approach is warranted given the well‐documented issues with reproducibility and repeatability in sperm morphology analysis.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Study design and conductcitation

    This 2007 study had several factors of bias: it concerned a small series (58 IVF cycles leading to 18 transfers were analysed), the criteria for deciding on ICSI or IVF were not given, nor were the exclusion criteria based on the results of female factors.

    “Nevertheless, this study had several factors of bias: it concerned a small series (58 IVF cycles leading to 18 transfers were analysed, the criteria for deciding on ICSI or IVF were not given, nor were the exclusion criteria based on the results of female factors).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [107] J. H. Check, A. Bollendorf, C. Wilson, D. Summers‐Chase, D. Horwath, and W. Yuan, “ A Retrospective Comparison of Pregnancy Outcome Following Conventional Oocyte Insemination vs Intracytoplasmic Sperm Injection for Isolated Abnormalities in Sperm Morphology Using Strict Criteria,” Journal of Andrology 28, no. 4 (2007): 607– 612, https://doi.org10.2164/jandrol.106.001941 17409463 source
56 of 56
  • The paper relies on this without support.

    The process of spermiogenesis generates numerous morphological traits that make sperm morphology analysis very difficult to interpret.

    “The process of spermiogenesis, a post‐meiotic phenomenon during which the head undergoes remodelling, generates numerous morphological ‘traits’ which make sperm morphology analysis very difficult to interpret.”
  • The paper relies on this without support.

    The number of motile spermatozoa after preparation is an important determinant of pregnancy rate after IUI.

    “While the importance of the number of motile spermatozoa after preparation is well established, the impact of sperm morphology on pregnancy rate and live birth rate after intra‐uterine insemination (IUI) is still debated.”
  • The paper relies on this without support.

    Teratozoospermia is often associated with oligoasthenozoospermia.

    “Many studies compared pregnancy outcomes according to levels of teratozoospermia without describing the other sperm parameters, whereas teratozoospermia is often associated with oligoasthenozoospermia.”
  • The paper relies on this without support.

    Polymorphic teratozoospermia is very often associated with OATS, which determines the indication of ICSI.

    “In male infertility, the choice between IVF and ICSI is scarcely influenced by sperm morphology, because on the one hand there are no applicable recommendations, and on the other hand polymorphic teratozoospermia is very often associated with OATS, which determines the indication of ICSI.”
  • The paper relies on this without support.

    Monomorphic syndromes are rare but often of genetic origin, and their diagnosis may lead to a change in medical management.

    “Monomorphic syndromes are rare but often of genetic origin, and their diagnosis may lead to a change in medical management.”
5 of 5

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • The EFSA guidance is assigned the Jankowski reference number

    Minor

    The discussion attributes EFSA guidance to reference [13], but reference [13] is a paper by Jankowski and colleagues; the EFSA guidance appears as reference [15].

  • An ICSI study is cited among studies of IUI prediction

    Minor

    Reference [95] is included in a list of studies evaluating prediction in IUI, but its title identifies its subject as ICSI cycles.

  • The stated publication year for study [110] differs from its reference

    Minor

    The results call the Pham study a 2025 publication, whereas its reference gives 2024 as the publication year.

  • The methods say all studies were Grade 1 or 2, but a Grade 3 study is reported

    Minor

    The methodological rationale describes the available studies as exclusively Grade 1 or 2. The results explicitly identify a Grade 3 study.

  • A kappa of 0.84 is called moderate despite the paper's stated scale

    Minor

    The methods classify kappa values greater than 0.8 as very good agreement, but the PICO 4 results call a kappa of 0.84 moderate.

5 of 5

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. WHO, 2010, WHO Laboratory Manual for the Examination of Human Semen and Sperm‐Cervical Mucus and Interaction

Cited by

Authors
Gatimel, N., Barbotin, A., Mery, L., Beauvillard, D., Bendayan, M., Boursier, A., Boueilh, T., Pereira, B., Chammas, J., Jacquet, J., Levy, R., Pfeffer, J., Pons‐Rejraji, H., Sanguinet, P., & Brugnon, F.
Affiliations
  • Inserm (FR)
  • Université de Lille (FR)
  • Centre Hospitalier Universitaire de Saint-Étienne (FR)
  • BLEFCO French National Federation of Biologistes des Laboratoires d'Etude De La Fécondation et De La Conservation de L’œuf Labège France
  • Université de Versailles Saint-Quentin-en-Yvelines (FR)
  • Centre Hospitalier Universitaire de Clermont-Ferrand (FR)
Corresponding author
Gatimel, Nicolas
Venue
Andrology
Publisher
Wiley
Published
2025-11-03
Volume
14
Issue
1
Pages
10-24
ISSN
  • 2047-2919 (ISSN-L)
  • 2047-2927
OpenAlex
W4415836688
Cited by
2
References
101
Citations by year
2026: 2
FWCI
1.34
Type
journal article
Language
en
Open access
Locations
  • Andrology (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, cc-by)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Sperm and Testicular Function
  • Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
  • Health Sciences › Health Professions › General Health Professions › Male Reproductive Health Studies
Keywords
sperm morphology assessment, male infertility, assisted reproduction, globozoospermia, spatial data infrastructure, MAI, computer-assisted sperm analysis, clinical guidelines, infertility workup
MeSH terms
France, Humans, Infertility, Male, Male, Spermatozoa, Semen Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-26.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-26.

Cited sources are checked by gpt-6-sol.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review